Ebola virus may have re-emerged in a woman a year after she survived an acute infection, potentially leading to the infection of her husband and two of their sons.
Australian researchers have developed what is claimed to be the world's first blood test capable of detecting melanoma in its early stages.
Upstream Medical Technologies has developed a biomarker-based diagnostic test to rule out the risk of imminent heart attack for the significant number of people presenting at hospital with chest pain.
University of Leicester experts in association with the spin-off company MIP Diagnostics have developed polymeric materials with molecular recognition capabilities which hold the potential to outperform natural antibodies in various diagnostic applications.
Laboratory professionals must have detailed clinical information to make decisions on the most effective testing for patients.
Technology co-developed at the Universities of Oxford and Sao Paulo State University will be commercialised by spinout company Oxford Impedance Diagnostics (OID), offering the potential for the development of ultrasensitive fast diagnostic tests for a range of diseases.
Tanaka Kikinzoku Kogyo has developed what is said to be the world's first kit able to directly detect the Zika virus (ZIKV) in blood.
Atomo Diagnostics has secured $1.38 million to assist in the development and commercialisation of new rapid tests for the detection of dengue and chikungunya viruses, which are leading causes of illness and death in the tropics and subtropics.
Massachusetts General Hospital will serve as a key testing site for a multicentred instrument precision study involving Royal Philips' digital pathology whole slide imaging IntelliSite Solution.
Scientists from the California Institute of Technology have invented a technique that will help bring emerging diagnostic capabilities out of laboratories and to the point of care.
Researchers have developed an online calculator that can help doctors to quickly and accurately predict liver fibrosis.
Opting to manage point-of-care testing in an overall framework for diversified testing is an opportunity for progressive laboratories rather than a threat.
Associate Professor Chamindie Punyadeera is looking to produce a heart failure test that is quick and easy to administer, by screening saliva instead of blood.
The ESCMID is imploring global healthcare professionals and bodies to take a more active role in the growing problem of fungal resistance. The society believes that fungal infections are neglected worldwide, despite the fact that over 300 million people of all ages suffer from a serious fungal infection every year.
Integrated DNA Technologies and Ubiquitome have collaborated on the development of technology that can detect the Ebola virus in the field. The companies' assay and PCR device will be used to detect Zaire ebolavirus, the species involved in the 2013–2015 West African Ebola outbreak.